Barinthus Biotherapeutics moves to deregister ADS under Exchange Act Section 12(g)

• Barinthus Biotherapeutics filed to terminate SEC registration of its American Depositary Shares, moving to deregister and delist the securities.
• Holder count for the American Depositary Shares stood at 1 as of the filing date.
• The termination notice was signed on Sept. 21, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Barinthus Biotherapeutics plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-109305), on September 21, 2026, and is solely responsible for the information contained therein.